Labdanum Resin from Cistus ladanifer L. as a Source of Compounds with Anti-Diabetic, Neuroprotective and Anti-Proliferative Activity
- PMID: 38792084
- PMCID: PMC11124373
- DOI: 10.3390/molecules29102222
Labdanum Resin from Cistus ladanifer L. as a Source of Compounds with Anti-Diabetic, Neuroprotective and Anti-Proliferative Activity
Abstract
Labdanum resin or "gum" can be obtained from Cistus ladanifer L. by two different extraction methods: the Zamorean and the Andalusian processes. Although its main use is in the fragrance and perfumery sectors, ethnobotanical reports describe its use for medicinal purposes in managing hyperglycemia and mental illnesses. However, data concerning the bioactivities and pharmacological applications are scarce. In this work, it was found that the yield of labdanum resin extracted by the Andalusian process was 25-fold higher than the Zamorean one. Both resins were purified as absolutes, and the Andalusian absolute was purified into diterpenoid and flavonoid fractions. GC-EI-MS analysis confirmed the presence of phenylpropanoids, labdane-type diterpenoids, and methylated flavonoids, which are already described in the literature, but revealed other compounds, and showed that the different extracts presented distinct chemical profile. The potential antidiabetic activity, by inhibition of α-amylase and α-glucosidase, and the potential neuroprotective activity, by inhibition of acetylcholinesterase, were investigated. Diterpenoid fraction produced the higher α-amylase inhibitory effect (~30% and ~40% at 0.5 and 1 mg/mL, respectively). Zamorean absolute showed the highest α-glucosidase inhibitory effect (~14% and ~24%, at 0.5 and 1 mg/mL, respectively). Andalusian absolute showed the highest acetylcholinesterase inhibitory effect (~70% and ~75%, at 0.5 and 1 mg/mL, respectively). Using Caco-2 and HepG2 cell lines, Andalusian absolute and its purified fractions showed moderate cytotoxic/anti-proliferative activity at 24 h exposure (IC50 = 45-70 µg/mL, for Caco-2; IC50 = 60-80 µg/mL, for HepG2), whereas Zamorean absolute did not produce cytotoxicity (IC50 ≥ 200.00 µg/mL). Here we show, for the first time, that labdanum resin obtained by the Andalusian process, and its fractions, are composed of phytochemicals with anti-diabetic, neuroprotective and anti-proliferative potential, which are worth investigating for the pharmaceutical industry. However, toxic side-effects must also be addressed when using these products by ingestion, as done traditionally.
Keywords: acetylcholinesterase; cytotoxic activity; labdane-type diterpenoids; labdanum resin; methylated flavonoids; α-amylase; α-glucosidase.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Labdanum Resin from Cistus ladanifer L.: A Natural and Sustainable Ingredient for Skin Care Cosmetics with Relevant Cosmeceutical Bioactivities.Plants (Basel). 2022 May 31;11(11):1477. doi: 10.3390/plants11111477. Plants (Basel). 2022. PMID: 35684251 Free PMC article.
-
Labdanum and Labdanes of Cistus creticus and C. ladanifer: Anti-Borrelia activity and its phytochemical profiling✰.Phytomedicine. 2019 Jul;60:152977. doi: 10.1016/j.phymed.2019.152977. Epub 2019 May 31. Phytomedicine. 2019. PMID: 31474477
-
The old pharmaceutical oleoresin labdanum of Cistus creticus L. exerts pronounced in vitro anti-dengue virus activity.J Ethnopharmacol. 2020 Jul 15;257:112316. doi: 10.1016/j.jep.2019.112316. Epub 2019 Oct 26. J Ethnopharmacol. 2020. PMID: 31669444
-
Identification of α-Glucosidase Inhibitors from Scutellaria edelbergii: ESI-LC-MS and Computational Approach.Molecules. 2022 Feb 16;27(4):1322. doi: 10.3390/molecules27041322. Molecules. 2022. PMID: 35209111 Free PMC article.
-
Flavonoids as potential agents in the management of type 2 diabetes through the modulation of α-amylase and α-glucosidase activity: a review.Crit Rev Food Sci Nutr. 2022;62(12):3137-3207. doi: 10.1080/10408398.2020.1862755. Epub 2021 Jan 11. Crit Rev Food Sci Nutr. 2022. PMID: 33427491 Review.
Cited by
-
Characterising the Metabolomic Diversity and Biological Potentials of Extracts from Different Parts of Two Cistus Species Using UHPLC-MS/MS and In Vitro Techniques.Pathogens. 2024 Sep 13;13(9):795. doi: 10.3390/pathogens13090795. Pathogens. 2024. PMID: 39338986 Free PMC article.
References
-
- Godinho-Ferreira P., Azevedo A., Rego F. Carta da tipologia florestal de Portugal Continental. Silva Lusit. 2005;13:1–34.
-
- Demoly J.P., Montserrat P. Cistus. In: Castroviejo S., editor. Flora Ibérica. CSIC (Centro Superior Investigacion Cientifica); Madrid, Spain: 1993. pp. 319–337.
-
- Montero G., López-Leiva C., Ruiz-Peinado R., López-Senespleda E., Onrubia R., Pasalodos M. Producción de Biomasa Y Fijación de Carbono Por Los Matorrales Españoles Y Por El Horizonte Orgánico Superficial de Los Suelos Forestales. Ministerio De Agricultura, Pesca Y Alimentación, Secretaría General Técnica Spain; Madrid, Spain: 2020. pp. 100–101.
-
- Mendes P., Meireles C., Vila-Viçosa C., Musarella C., Pinto-Gomes C. Best management practices to face degraded territories occupied by Cistus ladanifer shrublands–Portugal case study. Plant Biosyst. -Int. J. Deal. All Asp. Plant Biol. 2015;149:494–502.
-
- Frazão D.F., Gonçalves J.C., Silva A.M., Delgado F. Rockrose Land Management: Contribution of Periodic Harvesting to Increase Value and to Control Cistus ladanifer L. Shrublands. Forests. 2023;14:638. doi: 10.3390/f14030638. - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous